Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis

被引:6
|
作者
Cong, Shu-Yan
Pepers, Barry A.
Roos, Raymund A. C.
van Ommen, Gert-Jan B.
Dorsman, Josephine C.
机构
[1] Leiden Univ, Med Ctr, CBG, Ctr Human & Clin Genet, NL-2333 AL Leiden, Netherlands
[2] China Med Univ, Affiliated Hosp 2, Dept Neurol, Shenyang, Peoples R China
[3] Leiden Univ, Ctr Med, Dept Neurol, Leiden, Netherlands
[4] Ctr Med Syst Biol, Leiden, Netherlands
[5] Ctr Med Syst Biol, Amsterdam, Netherlands
[6] Ctr Med Syst Biol, Rotterdam, Netherlands
[7] Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands
关键词
Huntington's disease; N-terminal fragments of huntingtin; native property; molecular pathogenesis;
D O I
10.1016/j.expneurol.2005.11.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
N-terminal fragments of huntingtin containing an expanded polyglutamine stretch play an important role in the molecular pathogenesis of Huntington's disease. Their ultimate accumulation in insoluble protein aggregates constitutes an important pathological hallmark of Huntington's disease. We report on systematic biochemical comparison studies of soluble wild type and mutant N-terminal huntingtin fragments. The results show that soluble wild type exon 1 fragments are predominantly present in higher molecular weight complexes with a molecular size of similar to 300 kDa, while their mutant counterparts are mainly present in their monomeric form. In contrast, longer N-terminal fragments corresponding to peptides produced by caspase cleavage do not display these differential properties. These findings suggest that especially an increased amount of monomeric form of small N-terminal mutant huntingtin fragments may facilitate aberrant interactions both with itself via the polyglutamine stretch and with other proteins and thereby contribute to molecular pathogenesis. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 19 条
  • [1] N-terminal fragments of mutant huntingtin form filamentous aggregates in HD brain
    Yi, H
    Li, SH
    Li, XJ
    Hersch, SM
    Gutekunst, CA
    ELECTRON MICROSCOPY 1998, VOL 1: GENERAL INTEREST AND INSTRUMENTATION, 1998, : 843 - 844
  • [2] Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells
    Ratovitski, Tamara
    Gucek, Marjan
    Jiang, Haibing
    Chighladze, Ekaterine
    Waldron, Elaine
    D'Ambola, James
    Hou, Zhipeng
    Liang, Yideng
    Poirier, Michelle A.
    Hirschhorn, Ricky R.
    Graham, Rona
    Hayden, Michael R.
    Cole, Robert N.
    Ross, Christopher A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (16) : 10855 - 10867
  • [3] Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis
    Kim, YJ
    Yi, Y
    Sapp, E
    Wang, YM
    Cuiffo, B
    Kegel, KB
    Qin, ZH
    Aronin, N
    DiFiglia, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12784 - 12789
  • [4] Complex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin
    Milewski, Michal
    Gawlinski, Pawel
    Bak, Daniel
    Matysiak, Agata
    Bal, Jerzy
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2015, 94 (05) : 179 - 189
  • [5] Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments
    Li, Xiang
    Wang, Chuan-En
    Huang, Shanshan
    Xu, Xingshun
    Li, Xiao-Jiang
    Li, He
    Li, Shihua
    HUMAN MOLECULAR GENETICS, 2010, 19 (12) : 2445 - 2455
  • [6] Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
    Cooper, JK
    Schilling, G
    Peters, MF
    Herring, WJ
    Sharp, AH
    Kaminsky, Z
    Masone, J
    Khan, FA
    Delanoy, M
    Borchelt, DR
    Dawson, VL
    Dawson, TM
    Ross, CA
    HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 783 - 790
  • [7] Allosteric activation of Hsp70 reduces mutant huntingtin levels, the clustering of N-terminal fragments, and their nuclear accumulation
    Pinho, Brigida R.
    Almeida, Liliana M.
    Duchen, Michael R.
    Oliveira, Jorge M. A.
    LIFE SCIENCES, 2021, 285
  • [8] A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin
    Damiano, Maria
    Diguet, Elsa
    Malgorn, Carole
    D'Aurelio, Marilena
    Galvan, Laurie
    Petit, Fanny
    Benhaim, Lucile
    Guillermier, Martine
    Houitte, Diane
    Dufour, Noelle
    Hantraye, Philippe
    Canals, Josep M.
    Alberch, Jordi
    Delzescaux, Thierry
    Deglon, Nicole
    Beal, M. Flint
    Brouillet, Emmanuel
    HUMAN MOLECULAR GENETICS, 2013, 22 (19) : 3869 - 3882
  • [9] Cellular toxicity of yeast prion protein Rnq1 can be modulated by N-terminal wild type huntingtin
    Sethi, Ratnika
    Patel, Vishal
    Saleh, Aliabbas A.
    Roy, Ipsita
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2016, 590 : 82 - 89
  • [10] Proteins which interact with wild-type and mutant N-terminal domains of human PrPc.
    Silverman, G
    Yao, H
    Strome, R
    Laplanche, JL
    Foncin, JF
    StGeorgeHyslop, P
    Fraser, PE
    Westaway, D
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05): : 99 - 99